The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010


Poster Presenter

Characterization of Baseline Cardiovascular Functions in the Conscious Freely-Moving Juvenile Non-Human Primate

Ali S. Faqi, John C. Resendez, and Theodore J. Baird
USA

Most nonclinical/clinical drug safety assessments are conducted in developmentally mature subjects, which may not represent the most appropriate test sample for evaluating compounds with pediatric-specific indications. When children are the primary population, age-appropriate studies in juvenile animals are important for assessing direct toxic or developmental risks. With emerging trends in biologics, the necessity of conducting juvenile toxicology studies in non-human primates (NHP) will likely increase.

The purpose of this study was to characterize the postnatal developmental progression of key cardiovascular safety endpoints in 7-14 month old juvenile NHPs. To assure a comprehensive evaluation, utilizing continuous data sampling procedures without complications associated with chemical or physical restraint; eight recently weaned cynomolgus macaques were surgically instrumented with radiotelemetry transmitters to measure systemic arterial pressures and body temperature, and to record a standard electrocardiogram (ECG). A pressure-sensitive catheter was introduced femorally and positioned within the descending aorta, and bipolar electrode implanted to record a Lead II ECG. To facilitate long-term vascular access, a femoral venous catheter was implanted and connected to a subcutaneous vascular access port. Heart rate, blood pressure, body temperature and the ECG were collected according to a bi-weekly schedule using PoNeMah (Ver 4.1) software.

Telemetry data, including standard ECG reference intervals (RR, PR, QRS, QT, QTc), heart rate, blood pressure, body temperature will be presented and compared to a reference historical control dataset previously collected from a large sample of adult NHP subjects (Gauvin et al., 2006, J Pharmacol Toxicol Methods 53:140-51). The nature and putative bases for observed differences in baseline values for these physiological variables between adult and developing juvenile animals will be discussed.














[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy